Omani (Inula helenium)

Inula helenium (elecampane) contains alantolactone and isoalantolactone as primary bioactive sesquiterpene lactones that exhibit anti-inflammatory and antimicrobial properties. These compounds work by suppressing neutrophil activity and inhibiting bacterial cell wall synthesis in pathogenic organisms.

Origin & History

Inula helenium, commonly known as elecampane or Omani, is a perennial herbaceous plant native to Europe and Asia, with its medicinal root and rhizome traditionally harvested for therapeutic use. The active components are extracted from dried roots through various methods including decoction (boiling in water), tincture (1:1 or 1:5 in 25% alcohol), cold infusion, or as powdered form.

Historical & Cultural Context

Used since ancient Roman and Greek times across Western, Ayurvedic, Traditional Chinese, and Irish ethnomedicine primarily for lung ailments including pneumonia, whooping cough, asthma, bronchitis, tuberculosis, and chronic coughs. Traditional applications also included digestive issues, use as a tonic, diaphoretic, diuretic, antimicrobial, and surgical antiseptic.

Health Benefits

• Anti-inflammatory effects on respiratory conditions - in vitro studies show neutrophil suppression comparable to budesonide (Preliminary evidence)
• Antimicrobial activity against Staphylococcus aureus - root extracts demonstrate anti-staphylococcal properties in laboratory studies (Preliminary evidence)
• Potential anticancer properties - sesquiterpene lactones like isoalantolactone show antiproliferative effects in brain, pancreatic, and breast cancer cell lines (Preliminary evidence)
• Digestive health support - contains inulin, a prebiotic polysaccharide traditionally used for digestive issues (Traditional evidence)
• Respiratory expectorant - recognized by British Herbal Pharmacopoeia as antitussive and expectorant, traditionally used for excess mucus conditions (Traditional evidence)

How It Works

Alantolactone and isoalantolactone, the primary sesquiterpene lactones in Inula helenium, inhibit neutrophil degranulation and reduce inflammatory mediator release in respiratory tissues. These compounds also disrupt bacterial peptidoglycan synthesis and interfere with Staphylococcus aureus cell membrane integrity. The anti-inflammatory effects occur through modulation of NF-κB signaling pathways and cyclooxygenase enzyme inhibition.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses were identified in the available research. Current evidence is limited to in vitro studies, animal models, and traditional use documentation, with sesquiterpene lactones demonstrating anti-inflammatory and anticancer effects only in laboratory settings.

Clinical Summary

Current evidence for Inula helenium is limited to preliminary in vitro studies demonstrating neutrophil suppression comparable to budesonide in laboratory models. Root extract studies show antimicrobial activity against Staphylococcus aureus with minimum inhibitory concentrations ranging from 125-250 μg/mL. No human clinical trials have been conducted to establish therapeutic efficacy or optimal dosing regimens. The evidence remains at the preclinical stage and requires human studies for validation.

Nutritional Profile

{"macronutrients": {"fiber": "Approximately 5-10% by weight", "protein": "Low, less than 1% by weight"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts"}, "minerals": {"Potassium": "Moderate levels, around 200 mg per 100g", "Calcium": "Low levels, approximately 30 mg per 100g"}}, "bioactive_compounds": {"sesquiterpene lactones": {"isoalantolactone": "Present, specific concentration not well-documented"}, "inulin": "High concentration, approximately 40% by weight"}, "bioavailability_notes": "Inulin is a type of soluble fiber that may aid in digestion and has prebiotic effects. Sesquiterpene lactones may have limited bioavailability due to their complex structure."}

Preparation & Dosage

Traditional dosages include: Decoction or dried root/rhizome 1.5-4g three times daily; Liquid extract (1:1 in 25% alcohol) 1.5-4mL three times daily; Tincture (1:5, 25%) 2-5mL three times daily; Powdered herb 2-4g daily; Cold infusion (1 tsp/cup steeped overnight) 1 cup three times daily. No clinically studied dosages available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Marshmallow root, Mullein, Thyme, Licorice root, Ivy leaf

Safety & Interactions

Inula helenium may cause allergic reactions in individuals sensitive to Asteraceae family plants, including contact dermatitis and respiratory irritation. The sesquiterpene lactones can potentially interact with anticoagulant medications by enhancing bleeding risk. Pregnant and breastfeeding women should avoid use due to lack of safety data and potential uterine stimulant effects. Large doses may cause gastrointestinal upset including nausea and digestive irritation.